Obinutuzumab Showed Significantly Positive Results in Published Phase III Lupus Nephritis Study
Exciting breaking news: A paper published in the highly prestigious journal New England Journal of Medicine and presented at...
April 3, 2020
The President and CEO of the LRA, Kenneth Farber wrote personally to Speaker Nancy Pelosi and Leader Kevin McCarthy in the House of Representatives and Leader Mitch McConnell and Leader Chuck Schumer in the Senate asking that “any COVID-19 response and recovery package include provisions to ensure lupus patients maintain access to one of the most important medications approved to treat symptoms of this debilitating disease.” He specifically asks that any legislation responding to the COVID-19 pandemic provide ·